Pablo Berlanga
15PUBLICATIONS
215CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (15)
Sort by Publication Date:
|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff
|Oct 22, 2025
Leukoencephalopathy, a Frequent Complication After High-Dose Methotrexate in Treatment of Osteosarcoma.Sandra Raimbault, Jean Louis Amegnizin, Audrey Longaud
|Oct 04, 2025
Chemo-Immunotherapy Rescue for High-Risk Neuroblastoma Patients With Progressive Disease Before High-Dose Chemotherapy: Real-World Data From the SACHA-France Study.Claudia Pasqualini, Stéphanie Proust, Gudrun Schleiermacher
|Sep 19, 2025
Recurrent and Refractory Ewing Sarcoma Phase I/II Trials: Current Perspective From the Euro-Ewing Consortium.Antonio Juan Ribelles, Arthur Felix, Nuria Benavent
Pageof 3
Frequent Collaborators
4 joint publications
Gudrun Schleiermacher
3 joint publications
Birgit Geoerger
3 joint publications
Lee Aymar Ndounga-Diakou
3 joint publications
Nicolas André
3 joint publications
Gaelle Pierron
2 joint publications
Samuel Abbou
2 joint publications
Daniel Orbach
2 joint publications
Nadège Corradini
2 joint publications
Max van Noesel
2 joint publications
Anne-Sophie Defachelles